Publications by authors named "Xing Junchao"

Article Synopsis
  • Tissue-engineered bones (TEBs) are limited in their application due to issues with viable cells, but a method using freeze-drying created functional proteins-based TEBs (FP-TEBs) without living cells.
  • The research focused on understanding the FP-TEBs' ability to promote blood vessel formation (angiogenesis) and bone growth (osteogenesis) in live subjects, using qPCR arrays to measure relevant molecules.
  • Key findings identified the CXCR2 receptor as crucial for these processes, with specific signaling pathways involving Src, MAP4K4, and p38 MAPK significantly affecting the function of CXCR2.
View Article and Find Full Text PDF

Objective: This study aimed to investigate the techniques and indications of upper sacroiliac screw fixation for the dysmorphic sacrum.

Methods: The dysmorphic sacra were selected from 267 three-dimensional pelvic models. The dysmorphic sacra which couldn't accommodate a 7.

View Article and Find Full Text PDF

Fungal pathogens can induce canker lesions, wilting, and even dieback in many species. Trees can suffer serious physiological effects from stem cankers. In this study, we investigated the effects of (.

View Article and Find Full Text PDF

Homing of mesenchymal stem cells (MSCs) to the defect site is indispensable for bone repair. Local endothelial cells (ECs) can recruit MSCs; however, the mechanism remains unclear, especially in the context of the inflammatory microenvironment. This study was aimed to investigate the role of ECs in MSCs migration during the inflammatory phase of bone repair.

View Article and Find Full Text PDF

Tissue-engineered bones (TEB) are a promising strategy for treating large segmental bone defects. However, the application of TEB is greatly limited by technical and logistical issues caused by the viable cells used. The aim of the present study was to devise novel TEB, termed functional TEB (fTEB) using devitalized mesenchymal stem cells (MSCs) with the functional proteins retained.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to assess the effectiveness of an allogeneic bone cage (Biocage) for treating lumbar degenerative disease in patients who have a high risk of not achieving fusion after surgery.
  • - A total of 67 patients were split into two groups (Biocage and PEEK) and followed for 24 to 48 months to compare fusion rates and clinical outcomes.
  • - Results showed that while the Biocage had a slightly higher fusion rate and better intervertebral foramen height, both treatments resulted in good clinical outcomes, confirming the Biocage's safety and effectiveness.
View Article and Find Full Text PDF

The treatment of bone defects has always been a challenge for orthopedic surgeons. The development of tissue engineering technology provides a novel method for repairing bone defects and has been used in animal experiments and clinical trials. However, there are few clinical studies on comparing the long-term outcomes of tissue-engineered bones (TEBs) and other bone grafts in treating bone defects, and the long-term efficiency of TEBs remains controversial.

View Article and Find Full Text PDF

Apoptotic bodies (ABs) traditionally considered as garbage bags that enclose residual components of dead cells are gaining increasing attentions due to their potential roles in intercellular communications. In bone turn over, at the end of bone resorption phase, most osteoclasts undergo apoptosis, generating large amounts of ABs. However, it remains unclear of the role of osteoclast-derived ABs in bone remodeling.

View Article and Find Full Text PDF

Purpose: This retrospective study aimed to evaluate the curative effect of allografts in combination with bone marrow enrichment realised by selective cell retention (SCR) technology in treating adolescent idiopathic scoliosis (AIS).

Methods: From July 2014 to September 2016, 18 consecutive patients with AIS were treated by posterior fusion and pedicle screw instrumentation. Bone marrow aspirates were obtained and enriched by SCR technology to fabricate bone grafts in combination with allogeneic bones, which were implanted for spinal fusion.

View Article and Find Full Text PDF
Article Synopsis
  • Bone defects in patients present a significant challenge in orthopedic clinics, prompting the exploration of various treatment methods, with none proving fully effective until now.
  • Recent research involved using individual tissue-engineered bones (iTEBs) made from autologous bone marrow stem cells and allogenic decalcified bone matrix to treat 26 patients with these defects, resulting in positive long-term outcomes.
  • The study found significant improvements in healing times and functional recovery, with no major adverse effects like tumor formation or disease transmission, confirming iTEBs as a safe and effective solution, particularly for patients with limited autograft options.
View Article and Find Full Text PDF

Background And Aims: Host-derived cells play crucial roles in the regeneration process of tissue-engineered constructs (TECs) during the treatment of large segmental bone defects (LSBDs). However, their identity, source, and cell recruitment mechanisms remain elusive.

Methods: A complex model was created using mice by combining methods of GFP bone marrow transplantation (GFP-BMT), parabiosis (GFP-BMT and wild-type mice), and femoral LSBD, followed by implantation of TECs or DBM scaffolds.

View Article and Find Full Text PDF

Carbon starvation is the current leading hypothesis of plant mortality mechanisms under drought stress; recently, it is also used to explain tree die-off in plant diseases. However, the molecular biology of the carbon starvation pathway is unclear. Here, using a punch inoculation system, we conducted transcriptome and physiological assays to investigate pathogen response in poplar stems at the early stages of Botryosphaeria and Valsa canker diseases.

View Article and Find Full Text PDF

Bone repair involves bone resorption through osteoclastogenesis and the stimulation of neovascularization and osteogenesis by endothelial progenitor cells (EPCs). However, the role of EPCs in osteoclastogenesis is unclear. In this study, we assess the effects of EPC-derived exosomes on the migration and osteoclastic differentiation of primary mouse bone marrow-derived macrophages (BMMs) in vitro using immunofluorescence, western blotting, RT-PCR and Transwell assays.

View Article and Find Full Text PDF

Patient-specific individual tissue-engineered bones (iTEBs) have been recognized as a promising strategy for treating large bone defects. However, current construction protocols of iTEBs vary between lots and lack standardization and quality control, hampering further research and application. This study was aimed to detail a standardized constructing protocol for iTEBs, which can be used for both clinical and experimental purposes.

View Article and Find Full Text PDF

Background/aims: Tissue engineering bone transplantation with bone marrow mesenchymal stem cells (BMSCs) is an effective technology to treat massive bone loss, while molecular regulation of the bone regeneration processes remains poorly understood. Here, we aimed to assess the role of interleukin-8 (IL-8) in the recruitment of host cells by seeded BMSCs and in the bone regeneration.

Methods: A transwell assay was performed to examine the role of IL-8/CXCR1/CXCR2/PI3k/Akt on the migration potential of hBMSCs.

View Article and Find Full Text PDF

Objectives: The role of vitamin D (VD) in innate and adaptive immune responses to tuberculosis is still unclear. Our research was aimed to uncover the effect of VD on Th17 cells and elucidate potential molecular mechanism.

Materials And Methods: VDR-deficient and wild-type mice were used to obtain CD4 T cells.

View Article and Find Full Text PDF

Nitrogen-containing bisphosphonates including alendronate (ALN) are the current first line antiresorptive drug in treating osteoporosis. In our study, we found that ALN administration impaired the secretion of platelet derived growth factor-BB (PDGF-BB), the most important angiogenic cytokines produced by preosteoclast (POC), in both sham and ovariectomized (OVX) mice. To further understand this phenomenon, we induced bone marrow macrophages (BMMs) to POCs in vitro and detected the effects of ALN particularly in POCs.

View Article and Find Full Text PDF
Article Synopsis
  • Tissue-engineered constructs (TECs) are promising for treating large bone defects and can be enhanced by mesenchymal stem cells (MSCs) that aid in blood vessel formation.
  • The study investigated how MSCs influence the migration of endothelial progenitor cells (EPCs) through the C-X-C chemokine receptor 2 (CXCR2) and its signaling pathways.
  • Findings revealed that blocking CXCR2 halted EPC migration and subsequent blood vessel formation and bone repair, identifying the Src-PKL/Vav2-Rac1 signaling pathway as a key mechanism.
View Article and Find Full Text PDF

Unlabelled: Easily accessible and effective bone grafts are in urgent need in clinic. The selective cell retention (SCR) strategy, by which osteogenesis-related cells and factors are enriched from bone marrow into bio-scaffolds, holds great promise. However, the retention efficacy is limited by the relatively low densities of osteogenesis-related cells and factors in marrow; in addition, a lack of satisfactory surface modifiers for scaffolds further exacerbates the dilemma.

View Article and Find Full Text PDF

Background: The pathological fracture is a most important complication during bone cyst and can be prevented by early focus clearance and bone grafting. Tissue-engineered bone (TEB) with outstanding osteogenesis is a better choice for bone repair. Here, we firstly reported that TEB was used to heal bone cyst.

View Article and Find Full Text PDF

Tissue-engineered constructs (TECs) seeded with mesenchymal stem cells (MSCs) represent a therapy for large bone defects. However, massive cell death in TECs in the early postimplantation period prompted us to investigate the osteoinductive mechanism of TECs. Previous studies demonstrated that stem cell extracts retained equivalent levels of bioactive proteins and exhibited an osteoinductive nature similar to that of intact cells.

View Article and Find Full Text PDF

In clinical practice, the prolonged duration, high cost, critical technique requirements, and ethical issues make the classical construction method of tissue-engineered bones difficult to apply widely. The major essentials in tissue engineering strategies include seed cells, growth factors, and scaffolds. This study aimed to incorporate these factors in a rapid and cost-effective manner.

View Article and Find Full Text PDF

To date, various types of cells for seeding regenerative scaffolds have been used for bone tissue engineering. Among seed cells, the mesenchymal stem cells derived from human umbilical cord Wharton's jelly (hUCMSCs) represent a promising candidate and hold potential for bone tissue engineering due to the the lack of ethical controversies, accessibility, sourced by non-invasive procedures for donors, a reduced risk of contamination, osteogenic differentiation capacities, and higher immunomodulatory capacity. However, the current culture methods are somewhat complicated and inefficient and often fail to make the best use of the umbilical cord (UC) tissues.

View Article and Find Full Text PDF
Article Synopsis
  • A study aimed to create a reliable bilateral femoral defect model in mice to explore how bone defects heal in tissue engineering.
  • Bone marrow mesenchymal stem cells (mBMSCs) were harvested from donor mice and used with scaffolds to develop tissue-engineered bones; these were tested in a model involving 36 mice with surgically created bone defects.
  • Results showed that the use of mBMSCs accelerated bone healing and attracted more endothelial progenitor cells, establishing a practical model for future research in bone tissue engineering.
View Article and Find Full Text PDF

Purpose: This study focuses on nanoscale self-assembly peptides (SAP) modified demineralized bone matrix (DBM) which provided a more effective osteogenesis and regeneration for critically-sized femur defects in goats using the selective cell retention (SCR) strategy.

Methods: RADA16-I peptide was used to modify DBM and formed a composite scaffold (SAP/DBM). The morphological change and dynamic expression of osteogenic genes of mesenchymal stem cells (MSCs) derived from marrow in SAP/DBM was observed.

View Article and Find Full Text PDF